Home › Funds › Farallon Capital Management › ELV
Farallon Capital Management position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Latest position (Q3 2023)381.33K sh
Reported value held$166.04M
Portfolio Weight0.84%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 854.97K | $318.73M | New |
| Q4 2021 | 755.06K | $350.00M | Reduce |
| Q1 2022 | 768.77K | $377.64M | Add |
| Q2 2022 | 826.48K | $398.84M | Add |
| Q3 2022 | 801.40K | $364.03M | Reduce |
| Q4 2022 | 634.30K | $325.38M | Reduce |
| Q1 2023 | 673.63K | $309.74M | Add |
| Q2 2023 | 445.33K | $197.86M | Reduce |
| Q3 2023 | 381.33K | $166.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ELV
- Vanguard Group 23.02M sh · $8.07B · Q4 2025
- BlackRock Inc 18.99M sh · $7.34B · Q2 2026
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- Geode Capital Management 5.17M sh · $1.99B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- Invesco Ltd 4.23M sh · $1.64B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- Norges Bank Investment Management 3.96M sh · $1.53B · Q2 2026
- BNY Mellon 3.22M sh · $1.25B · Q2 2026
- Fidelity Management & Research (FMR) 3.13M sh · $1.21B · Q2 2026
- Morgan Stanley 2.61M sh · $1.01B · Q2 2026
- Citigroup Inc 2.15M sh · $829.87M · Q2 2026